Searchable abstracts of presentations at key conferences in endocrinology

ea0081ep15 | Adrenal and Cardiovascular Endocrinology | ECE2022

Don’t break my heart: sparing the knife in SDHB mutated cardiac paraganglioma treated with cabozantinib

Carafone Lindsay , Archibald William , Victor Adrienne , Harbuz-Miller Inga

Introduction: Cardiac paragangliomas are rare endocrine neoplasms. Surgical resection is first line treatment. Here, we describe a case of cardiac paraganglioma where surgical resection was aborted due to involvement of important cardiac structures. Systemic therapy was instead pursued with tyrosine kinase inhibitor cabozantinib.Case: A 64-year-old man with a past medical history significant for tobacco use and poorly controlled type 2 diabetes mellitus ...